190 related articles for article (PubMed ID: 32576812)
21. Backbone (1)H, (13)C and (15)N resonance assignments of the OB domain of the single stranded DNA-binding protein hSSB1 (NABP2/OBFC2B) and chemical shift mapping of the DNA-binding interface.
Kariawasam R; Touma C; Cubeddu L; Gamsjaeger R
Biomol NMR Assign; 2016 Oct; 10(2):297-300. PubMed ID: 27193589
[TBL] [Abstract][Full Text] [Related]
22. Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation.
Horejsí Z; Falck J; Bakkenist CJ; Kastan MB; Lukas J; Bartek J
Oncogene; 2004 Apr; 23(17):3122-7. PubMed ID: 15048089
[TBL] [Abstract][Full Text] [Related]
23. A data-driven structural model of hSSB1 (NABP2/OBFC2B) self-oligomerization.
Touma C; Adams MN; Ashton NW; Mizzi M; El-Kamand S; Richard DJ; Cubeddu L; Gamsjaeger R
Nucleic Acids Res; 2017 Aug; 45(14):8609-8620. PubMed ID: 28609781
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a novel posttranslational modification in neuronal nitric oxide synthase by small ubiquitin-related modifier-1.
Watanabe M; Itoh K
Biochim Biophys Acta; 2011 Jul; 1814(7):900-7. PubMed ID: 21545853
[TBL] [Abstract][Full Text] [Related]
25. 2-D08 as a SUMOylation inhibitor induced ROS accumulation mediates apoptosis of acute myeloid leukemia cells possibly through the deSUMOylation of NOX2.
Zhou P; Chen X; Li M; Tan J; Zhang Y; Yuan W; Zhou J; Wang G
Biochem Biophys Res Commun; 2019 Jun; 513(4):1063-1069. PubMed ID: 31010676
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of RIF1 SUMOylation is regulated by PIAS4 in the maintenance of Genomic Stability.
Kumar R; Cheok CF
Sci Rep; 2017 Dec; 7(1):17367. PubMed ID: 29234018
[TBL] [Abstract][Full Text] [Related]
27. hSSB1 (NABP2/OBFC2B) is regulated by oxidative stress.
Paquet N; Adams MN; Ashton NW; Touma C; Gamsjaeger R; Cubeddu L; Leong V; Beard S; Bolderson E; Botting CH; O'Byrne KJ; Richard DJ
Sci Rep; 2016 Jun; 6():27446. PubMed ID: 27273218
[TBL] [Abstract][Full Text] [Related]
28. Multisite SUMOylation restrains DNA polymerase η interactions with DNA damage sites.
Guérillon C; Smedegaard S; Hendriks IA; Nielsen ML; Mailand N
J Biol Chem; 2020 Jun; 295(25):8350-8362. PubMed ID: 32350109
[TBL] [Abstract][Full Text] [Related]
29. Nuclear accumulation of UBC9 contributes to SUMOylation of lamin A/C and nucleophagy in response to DNA damage.
Li Y; Jiang X; Zhang Y; Gao Z; Liu Y; Hu J; Hu X; Li L; Shi J; Gao N
J Exp Clin Cancer Res; 2019 Feb; 38(1):67. PubMed ID: 30744690
[TBL] [Abstract][Full Text] [Related]
30. SUMO pathway components as possible cancer biomarkers.
Mattoscio D; Chiocca S
Future Oncol; 2015; 11(11):1599-610. PubMed ID: 26043214
[TBL] [Abstract][Full Text] [Related]
31. A fine-tuning mechanism underlying self-control for autophagy: deSUMOylation of BECN1 by SENP3.
Liu K; Guo C; Lao Y; Yang J; Chen F; Zhao Y; Yang Y; Yang J; Yi J
Autophagy; 2020 Jun; 16(6):975-990. PubMed ID: 31373534
[TBL] [Abstract][Full Text] [Related]
32. A core hSSB1-INTS complex participates in the DNA damage response.
Zhang F; Ma T; Yu X
J Cell Sci; 2013 Nov; 126(Pt 21):4850-5. PubMed ID: 23986477
[TBL] [Abstract][Full Text] [Related]
33. Target proteins of C/EBPalphap30 in AML: C/EBPalphap30 enhances sumoylation of C/EBPalphap42 via up-regulation of Ubc9.
Geletu M; Balkhi MY; Peer Zada AA; Christopeit M; Pulikkan JA; Trivedi AK; Tenen DG; Behre G
Blood; 2007 Nov; 110(9):3301-9. PubMed ID: 17671234
[TBL] [Abstract][Full Text] [Related]
34. HIC1 (hypermethylated in cancer 1) SUMOylation is dispensable for DNA repair but is essential for the apoptotic DNA damage response (DDR) to irreparable DNA double-strand breaks (DSBs).
Paget S; Dubuissez M; Dehennaut V; Nassour J; Harmon BT; Spruyt N; Loison I; Abbadie C; Rood BR; Leprince D
Oncotarget; 2017 Jan; 8(2):2916-2935. PubMed ID: 27935866
[TBL] [Abstract][Full Text] [Related]
35. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).
Niedenthal R
Methods Mol Biol; 2009; 497():63-79. PubMed ID: 19107411
[TBL] [Abstract][Full Text] [Related]
36. Sumoylation Pathway as Potential Therapeutic Targets in Cancer.
Gong L; Qi R; Li DW
Curr Mol Med; 2017; 16(10):900-905. PubMed ID: 28017138
[TBL] [Abstract][Full Text] [Related]
37. RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.
Yan J; Yang XP; Kim YS; Joo JH; Jetten AM
Biochem Biophys Res Commun; 2007 Oct; 362(1):132-138. PubMed ID: 17698038
[TBL] [Abstract][Full Text] [Related]
38. Spectomycin B1 as a novel SUMOylation inhibitor that directly binds to SUMO E2.
Hirohama M; Kumar A; Fukuda I; Matsuoka S; Igarashi Y; Saitoh H; Takagi M; Shin-ya K; Honda K; Kondoh Y; Saito T; Nakao Y; Osada H; Zhang KY; Yoshida M; Ito A
ACS Chem Biol; 2013 Dec; 8(12):2635-42. PubMed ID: 24143955
[TBL] [Abstract][Full Text] [Related]
39. The SUMO (Small Ubiquitin-like Modifier) Ligase PIAS3 Primes ATR for Checkpoint Activation.
Wu CS; Zou L
J Biol Chem; 2016 Jan; 291(1):279-90. PubMed ID: 26565033
[TBL] [Abstract][Full Text] [Related]
40. SUMO modification of Akt regulates global SUMOylation and substrate SUMOylation specificity through Akt phosphorylation of Ubc9 and SUMO1.
Lin CH; Liu SY; Lee EH
Oncogene; 2016 Feb; 35(5):595-607. PubMed ID: 25867063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
